Listed

CytomX Therapeutics, Inc.

CTMXNasdaqCIK 1501989HealthcareFiscal year ends Dec 31

Reports and events: 198 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

CytomX Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2023-05-0916:09 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019654
2023-04-2716:16 ETDEF 14AProxy statementPeriod 2023-06-140001140361-23-020944
2023-03-2716:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-009999
2023-03-2716:11 ET10-KAnnual reportPeriod 2022-12-310000950170-23-009991
2023-03-2716:06 ET10-K/AAnnual report, amendedPeriod 2021-12-310000950170-23-009984
2023-03-1015:36 ET8-K7.01 Regulation FD disclosure0001193125-23-067531
2023-02-2407:00 ET8-K4.02 Non-reliance on financial statements0001193125-23-047460
2023-01-0516:13 ET8-K1.01 Entry into a material agreement0001193125-23-002398
2022-11-2220:05 ET8-K1.01 Entry into a material agreement0001193125-22-290176
2022-11-0816:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-023210
2022-11-0816:03 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-023190
2022-09-2316:07 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-250137
2022-09-1316:11 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-243709
2022-08-0416:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-014751
2022-08-0416:07 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-014737
2022-07-1316:10 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors0001193125-22-192874
2022-07-0616:10 ET8-K8.01 Other events0001193125-22-188577
2022-06-2116:16 ET8-K5.07 Shareholder vote results0001193125-22-177650
2022-05-0516:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-007835
2022-05-0516:05 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-007806
2022-04-2716:20 ETDEF 14AProxy statementPeriod 2022-06-150001140361-22-016242
2022-04-1416:15 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-105580
2022-03-2316:33 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-082793
2022-03-0116:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-002526
2022-03-0116:06 ET10-KAnnual reportPeriod 2021-12-310000950170-22-002519
2022-02-1416:16 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-041752
2022-02-0709:00 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-029142
2022-01-1008:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-22-000174
2021-11-0416:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-003067
2021-11-0416:07 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-003053
2021-10-0408:46 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-290428
2021-08-0516:26 ET10-QQuarterly reportPeriod 2021-06-300000950170-21-000946
2021-08-0516:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-000939
2021-06-2219:17 ET8-K5.07 Shareholder vote results0001193125-21-195380
2021-05-0616:12 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-024969
2021-05-0616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-024964
2021-04-2816:32 ETDEF 14AProxy statementPeriod 2021-06-160001140361-21-014772
2021-03-0416:17 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-069514
2021-02-2416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-008088
2021-02-2416:07 ET10-KAnnual reportPeriod 2020-12-310001564590-21-008081
2021-01-2517:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-016452
2021-01-1917:09 ET8-K2.02 Results of operations; 8.01 Other events0001193125-21-011589
2020-12-2216:15 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-324542
2020-11-0516:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-051317
2020-11-0516:07 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-051302
2020-10-0616:15 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-264740
2020-08-0616:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-037749
2020-08-0616:06 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-037722
2020-06-2316:16 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-176532
2020-05-2917:10 ET8-K8.01 Other events0001193125-20-155943

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.